-
Kitsap Respiratory Illness Report: Week 12 (3/16/2025-3/22/2025)
In week ending March 22, local indicators for influenza continued to decrease but remained high, while local indicators for RSV remained elevated, and indicators for COVID-19 remained low. Other Puget Sound counties observed similar trends. Regional laboratory surveillance most frequently detected influenza A and rhinovirus among clinical respiratory specimens. 1.3% of emergency department (ED) visits were attributable to influenza, and…
-
Kitsap Respiratory Illness Report: February 19 – February 25
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.19.23-02.25.23. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,691 cumulative (17.6% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (490 since the start of…
-
Health Advisory: Increase COVID-19 Treatment Access, Prescribing and Uptake
Advisory or Update, COVID-19, Health Advisory, Health Alert, Immunization, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Provider ResourcesActions requested For questions, please contact our Immunizations/COVID Program at 360-728-2007. Background While COVID-19 treatment is shown to reduce hospitalization, it is under-used for high-risk patients with acute COVID-19. High-risk patients include: COVID-19 continues to cause between 2,000 and 4,000 deaths each week in the United States (see CDC’s Trends in Number of COVID-19 Cases…
-
Kitsap Respiratory Illness Report: February 12 – February 18
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Influenza, Influenza Update, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 7 of the Kitsap Respiratory Illness Report: 02.12.23-02.18.23. Summary: Local influenza activity is currently low, with 9 positive influenza tests in the past week (1,689 cumulative (18.2% of total tested) since 10/2/2022). RSV activity is currently low, with 4 positive RSV tests in the past week (488 since the start of…
-
Kitsap Respiratory Illness Report: February 5 – February 11
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness Report, Respiratory Illness ReportClick here to access week 6 of the Kitsap Respiratory Illness Report: 02.05.23-02.11.23. Summary: Local influenza activity is currently low, with 5 positive influenza tests in the past week (1,680 cumulative (18.9% of total tested) since 10/2/2022). RSV activity is currently low, with 2 positive RSV tests in the past week (484 since the start of…
-
Kitsap Respiratory Illness Report: January 29 – February 4
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Respiratory Illness ReportClick here to access week 4 of the Kitsap Respiratory Illness Report: 01.29.23-02.04.23. Summary: Local influenza activity is currently low, with 4 positive influenza tests in the past week (1,675 cumulative (19.7% of total tested) since 10/2/2022). RSV activity is currently elevated, with 6 positive RSV tests in the past week (482 since the start of…
-
Kitsap Respiratory Illness Report: January 22 – January 28
Advisory or Update, Communicable Disease Data Report, Influenza, Influenza Update, Respiratory Illness ReportClick here to access week 4 of the Kitsap Respiratory Illness Report: 01.22.2023 – 01.28.2023. Summary: Local influenza activity is currently low, with 2 positive influenza tests in the past week (1,671 cumulative (20.6% of total tested) since 10/2/2022). RSV activity is currently elevated, with 5 positive RSV tests in the past week (476 since the…
-
Evusheld no longer authorized for COVID-19 prevention
Advisory or Update, COVID-19, Infection Control, News and Alerts, News and Update, Novel Coronavirus, Prevention, Provider ResourcesOn January 26, 2023, the Food and Drug Administration (FDA) announced that Evusheld (tixagevimab co-packaged with cilgavimab) is not currently authorized for use in the U.S. Facilities and providers should continue to store Evusheld in the event that variants susceptible to Evusheld become more prevalent. Evusheld Effectiveness Evusheld is unlikely to be active against SARS-CoV-2 variants projected…
-
Health Advisory: EzriCare Artificial Tears linked to antibiotic-resistant infections
Advisory or Update, Emerging Diseases and Conditions, Health Advisory, Health Alert, Infection Control, News and Alerts, News and Update, Provider ResourcesActions Requested Background The Centers for Disease Control and Prevention (CDC) is investigating a multistate cluster of Verona Integron‐mediated Metallo‐β‐lactamase (VIM)‐ and Guiana‐Extended Spectrum‐β‐Lactamase (GES)‐ producing carbapenem‐resistant Pseudomonas aeruginosa (VIM‐GES‐CRPA) associated with multiple different infection types, including eye infections. Recent epidemiology and laboratory evidence link these infections to use of EzriCare Artificial Tears. These over-the-counter…
-
Health Advisory: King County measles case traveled through SeaTac airport
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Health Alert, Immunization, Immunizations, Measles, News and Alerts, News and Update, Notifiable Conditions, Provider Resources, Travel, VaccineActions Requested Background Current situation Seattle King County Public Health is investigating a local case of measles in an adult who was exposed while overseas. The case was at SeaTac airport and Providence Swedish First Hill Emergency Department during their infectious period before receiving the diagnosis of measles. The case did not wear a face…
-
Kitsap Respiratory Illness Report: January 15 – January 21, 2023
Click here to access week 3 of the Kitsap Respiratory Illness Report: 01.15.2023 – 01.21.2023. Summary: Local influenza activity is currently elevated, with 10 positive influenza tests in the past week (1,669 cumulative (21.4% of total tested) since 10/2/2022). RSV activity is currently elevated, with 8 positive RSV tests in the past week (471 since…
-
Kitsap Respiratory Illness Report: January 8 – January 14, 2023
Communicable Disease Data Report, Influenza, Influenza Update, News and Alerts, News and Update, Respiratory Illness ReportClick here to access week 2 of the Kitsap Respiratory Illness Report: 01.08.2023 – 01.14.2023. Summary: Local influenza activity is currently elevated, with 13 positive influenza tests in the past week (1,659 cumulative (22.3% of total tested) since 10/2/2022). RSV activity is currently elevated, with 9 positive RSV tests in the past week (463 since…
-
Update on Pfizer COVID-19 bivalent booster
Communicable Disease and Immunization Update, COVID-19, Immunization, Immunizations, News and Alerts, News and Update, Novel Coronavirus, Provider Resources, VaccineThe following information was shared by the Washington State Department of Health: On January 13, the CDC announced that they will be investigating a preliminary safety signal for the Pfizer Bivalent Booster. The safety signal was detected by the CDC’s Vaccine Safety Datalink. Other safety systems, databases, and countries are not seeing the same link,…